Multiplatform molecular profiling of male breast cancer (MBC) reveals significant differences in actionable targets from matched female breast carcinomas


Sherri Z Millis, MS, PhD,Joanne Xiu, PhD, Zoran Gatalica, MD, DSc, Joyce O'Shaughnessy, MD


Male breast cancer (MBC) is rare, occurring in ~1% of all breast cancers. While clinically characterized as being similar to postmenopausal ER+ BC, MBC has been much less characterized molecularly than female BC.

Download Publication